Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect
ACS Publications. Most Trusted. Most Cited. Most Read
Highly Specific Plasmonic Biosensors for Ultrasensitive MicroRNA Detection in Plasma from Pancreatic Cancer Patients
My Activity
  • Open Access
Letter

Highly Specific Plasmonic Biosensors for Ultrasensitive MicroRNA Detection in Plasma from Pancreatic Cancer Patients
Click to copy article linkArticle link copied!

View Author Information
Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United States
‡ § ∥ Department of Medicine, §Department of Biochemistry and Molecular Biology, and the Center for Pancreatic Cancer Research at the IU Simon Cancer Center, Indiana University School of Medicine, 980 W. Walnut Street, C549, Indianapolis, Indiana 46202, United States
Department of Physics, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United States
# Integrated Nanosystems Development Institute, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, Indianapolis, Indiana 46202, United States
*E-mail: [email protected] (R.S.).
*E-mail: [email protected] (M.K.).
Open PDFSupporting Information (1)

Nano Letters

Cite this: Nano Lett. 2014, 14, 12, 6955–6963
Click to copy citationCitation copied!
https://doi.org/10.1021/nl503220s
Published November 7, 2014

Copyright © 2014 American Chemical Society. This publication is licensed under these Terms of Use.

Abstract

Click to copy section linkSection link copied!

MicroRNAs (miRs) are small noncoding RNAs that regulate mRNA stability and/or translation. Because of their release into the circulation and their remarkable stability, miR levels in plasma and other biological fluids can serve as diagnostic and prognostic disease biomarkers. However, quantifying miRs in the circulation is challenging due to issues with sensitivity and specificity. This Letter describes for the first time the design and characterization of a regenerative, solid-state localized surface plasmon resonance (LSPR) sensor based on highly sensitive nanostructures (gold nanoprisms) that obviates the need for labels or amplification of the miRs. Our direct hybridization approach has enabled the detection of subfemtomolar concentration of miR-X (X = 21 and 10b) in human plasma in pancreatic cancer patients. Our LSPR-based measurements showed that the miR levels measured directly in patient plasma were at least 2-fold higher than following RNA extraction and quantification by reverse transcriptase-polymerase chain reaction. Through LSPR-based measurements we have shown nearly 4-fold higher concentrations of miR-10b than miR-21 in plasma of pancreatic cancer patients. We propose that our highly sensitive and selective detection approach for assaying miRs in plasma can be applied to many cancer types and disease states and should allow a rational approach for testing the utility of miRs as markers for early disease diagnosis and prognosis, which could allow for the design of effective individualized therapeutic approaches.

Copyright © 2014 American Chemical Society

Pancreatic ductal adenocarcinoma (PDAC)-related deaths are a major health concern in the United States since the five-year survival rate is only 6%. (1) A crucial contributor to this dismal statistic is the absence of a biomarker for early PDAC detection. Moreover, most patients with PDAC do not develop specific symptoms until the disease is quite advanced. Therefore, at clinical presentation, PDAC patients often have locally advanced and/or metastatic disease, which precludes effective therapy in the vast majority of patients. In this context microRNAs (miRs), (2) which are small single-stranded, noncoding RNAs often play a major role in cell proliferation, survival, migration, invasion, and metastasis in various cancers, (3-5) including PDAC. (6, 7) Moreover, miRs are released into the circulation, where they exhibit remarkable stability. Therefore, the development of sensitive and specific detection techniques, which precisely and quantitatively measure the concentration of miRs in their native environments such as blood or plasma, may provide a unique opportunity for developing diagnostic and prognostic markers in PDAC. (6-8)
Microarrays (9) and quantitative reverse transcription polymerase chain reaction (qRT-PCR) (10, 11) assays are routinely used to detect miRs. However, these methods are semiquantitative, require sequence-based amplification and radioactive labeling steps, and suffer from cross-hybridization and invalid internal controls. Other analytical techniques such as electrochemical (12, 13) and fluorescence-based assays (14) are also used to quantify the miRs. However, such techniques require either additional amplification or labeling, or complex electron/energy transfer processes, and cannot be performed in physiological media. A few label-free techniques such as photonic microring resonators, (15) nanopores, (16, 17) and nanoparticle-based biobarcode gel assay (18) can detect miRs associated with cancer patients. However, microring resonators suffer from low sensitivity and do not work in physiological media. Although nanopore-based sensors have shown the ability to detect miRs in the circulation of lung cancer patients, the technique requires a complicated fabrication procedure, a high probe concentration, and a specific probe signature. (16) The biobarcode gel technique relies on complex sandwich-type capturing methods, uses of the toxic chemical potassium cyanide, and may not be applicable to clinically relevant patient samples.
Plasmonic nanostructures have gained significant attention because of their geometrical feature-dependent localized surface plasmon resonance (LSPR) properties, (19-23) which can be further controlled by modulating their local dielectric environment. (21, 24) Utilizing these properties, several molecular (25, 26) and biological (27-34) sensors have been developed where analyte binding to nanostructure surface-bound receptors results in an increase in refractive index and consequently a LSPR peak shift. (35, 36) In this context, it has not been possible to detect and quantify sequence specific miRs by their direct hybridization to nanostructure probes followed by monitoring the LSPR properties of nanostructures without using labeling steps. We now report for the first time the fabrication of label-free, solid-state plasmonic biosensors for miR detection. The biosensing involves the direct hybridization of PDAC-relevant miRs in plasma to their complementary single-stranded DNAs (HS-C6-ssDNA) that were functionalized on the surface of gold nanoprisms attached onto a glass substrate. This construct serves as a plasmonic biosensor through monitoring the LSPR dipole peak (λLSPR). We also demonstrate that our sensors are extremely specific in miR detection and that addition of DNA-RNA duplex cleaving enzymes regenerates the sensor, allowing for multiple uses without compromising sensing efficiency.

Fabrication of the Plasmonic Biosensor for miRs Detection

Figure 1 represents the schematic diagram of our solid-state, label-free plasmonic biosensor fabrication for miR detection. Chemically synthesized gold nanoprisms (Figure 1a), which displayed their λLSPR at ∼797 nm upon attachment to solid substrate immersed in PBS buffer, were selected as nanoantennas for our biosensor fabrication because (1) their λLSPR peak position (in the 700–900 nm wavelength range) is particularly suitable for biomolecule detection because of negligible background scattering and adsorption of endogeneous chromophores from physiological media such as blood and plasma; (37, 38) (2) they have strong electromagnetic (EM) field enhancement at the sharp tips; (39, 40) (3) they exhibits a strong LSPR response to small changes in their surrounding environment; (36, 41-46) (4) their atomically smooth surface allows formation of a self-assembled monolayer (SAM) (47) of receptors with both a tightly packed lower layer of alkylthiols and a more loosely packed upper layer that provide the required space for duplex formation with complementary miR strands; (5) gold is nontoxic and stable under extreme physiological conditions; (48) and (6) the gold–sulfur bond is very stable with thiol-modified receptors making a strong covalent bond with the gold surface. Details describing the synthesis of gold nanoprisms and their attachment onto the silanized glass substrate are provided in Supporting Information. Recently, (49) we have shown that a molecular sensor fabricated using an ∼35 nm average edge-length gold nanoprisms displayed an unprecedentedly large 21 nm reversible shift upon a minor 0.6 nm increase in the thickness of the local dielectric environment. Therefore, gold nanoprisms of this size and geometry are unique and should provide extremely high sensitivity if plasmonic biosensors are fabricated using them, which is the scope of this Letter. This Letter provides the first example of LSPR-based miRs sensing in physiological media.

Figure 1

Figure 1. Design of plasmonic biosensors and detecting miR-X in various physiological media. (a) Chemically synthesized and freshly prepared gold nanoprisms were covalently attached onto a 3-mercaptopropyltriethoxysilane-functionalized glass coverslip (substrate). (b) Surface of gold nanoprisms was chemically modified with a 1.0 μM 1:1 mixture of SH-C6-ssDNA-X and PEG6-SH in PBS buffer (pH 7.4) to prepare the plasmonic biosensor. (c) Incubation of sensor in miR-X solution and formation of DNA duplex. (d) Schematic of the extinction spectrum of the biosensor collected in PBS buffer after modification with a 1.0 μM 1:1 mixture of SH-C6-ssDNA-X and PEG6-SH (blue curve). The extinction spectrum was again collected after incubation in miR-X solution and careful rinsing with PBS buffer to determine the new peak position (red curve). The extent of LSPR dipole peak shift (ΔλLSPR) depends on the concentration of miR-X used during the incubation in (c), which ranged from 100 nM to 50 fM. (e) Plot of ΔλLSPR versus log of miR-X concentrations used to determine the limit of detection. The image is not to scale.

For detection and quantification, our targets were miR-21 and miR-10b, because we have shown by locked nuclei acid–based in situ hybridization that they are overexpressed in pancreatic cells (PCCs) within the tumor mass (50, 51) and that circulating miR-10b may serve as biomarker for diagnosis of PDAC. (8) We designed the sensing strategy based on the hybridization between complementary probes (-C6-ssDNA-X, X = 21 and 10b) attached to gold nanoprisms and their target miRs. The introduction of spacers in-between the DNA probes was included to reduce steric hindrance between the probes and the miRs and therefore to enhance the hybridization and ultimately the sensitivity. As shown in Figure 1b, poly(ethylene glycol)6-thiols (PEG6-SH) were used as spacers because they avoid nonspecific adsorption of extraneous materials onto the nanoprism’s surface and are not reactive toward miRs or other biological constituents present in plasma. Previously, we demonstrated that functionalization of a nanoantenna’s surface with an equal mole ratio of receptor and spacer provided the best sensitivity and lowest limit of detection (LOD). (42) Therefore, a 1:1 ratio of HS–C6-ssDNA-X:PEG6-SH was used to prepare the plasmonic biosensors (Figure 1b). All the miRs and oligonucleotides sequences used in these studies are provided in Supporting Information, Table S1.
As illustrated in Figure 2a, we used UV–vis spectroscopy to monitor the changes in λLSPR of the gold nanoprisms at different functionalization steps. The functionalization of substrate-bound nanoprisms with 1:1 ratio of HS–C6-ssDNA-21:PEG6-SH resulted in an ∼20.5 ± 3.2 nm red-shift of λLSPR as a result of the increase in local refractive index, which suggested the attachment of both molecular species onto the nanoprism’s surface. These plasmonic biosensors were utilized for miR detection by incubating miR-21 (obtained from Sigma-Aldrich, U.S.A.) with concentration ranging from 100 nM to 50 fM in PBS buffer, 40% bovine plasma, or 40% human plasma. The λLSPR response of gold nanoprisms for each miR-21 concentration was measured where the highest 18.8 ± 1.9 nm λLSPR red shift was observed for 100 nM miR-21 (Figure 2a, blue) in PBS buffer. We hypothesize that the λLSPR red-shift is due to hybridization between ssDNA-21 and miR-21. It was found that the magnitude of the λLSPR shift was concentration dependent, where 50 fM miR-21 caused a 3.7 ± 0.3 nm λLSPR red shift in PBS buffer. Figure 2b illustrates the magnitude of the λLSPR shift (ΔλLSPR) upon DNA/RNA duplex formation for various miR-21 concentrations in the three different media. Evidently higher concentrations of miR-21 induced a larger number of ssDNA-21 strands to convert to DNA/RNA duplexes and consequently a larger change in the local refractive index around the nanoprisms, which results in a larger value of ΔλLSPR.

Figure 2

Figure 2. MicroRNA detection using label-free plasmonic biosensors. (a) Monitoring LSPR dipole peak (λLSPR) changes by UV–visible absorption spectra of gold nanoprisms during various functionalization steps: before (black, λLSPR = 800 nm) and after functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-21/PEG6-SH (red, λLSPR = 821 nm), and after incubation with 100 nM miR-21 solution in PBS buffer (blue, λLSPR = 839 nm). (b) average λLSPR peak shift (ΔλLSPR) of gold nanoprisms functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-21/PEG6-SH after incubation in different concentrations of miR-21 in PBS buffer (red triangles), 40% human plasma (black squares), and 40% bovine plasma (blue diamonds). The ΔλLSPR were calculated by taking the difference between the λLSPR peak position of the plasmonic biosensor after and before the hybridization with miR-21 in the various media. (c) Average ΔλLSPR of the plasmonic biosensor functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-10b/PEG6-SH after hybridization with different miR-10b concentrations in PBS buffer (red triangles), in 40% human plasma (black squares), and in 40% bovine plasma (blue diamonds). All extinction spectra recorded after miR-X incubation were measured in PBS buffer after rinsing with PBS buffer.

The highest red shift of 18.8 ± 1.9 nm we observed for 100 nM miR-21 incubation with our plasmonic biosensor is significant considering only an ∼5% change in the refractive index upon ssDNA/RNA duplex formation. (52) We believe such a high sensitivity of our plasmonic biosensors is because of the unique LSPR properties of our gold nanoprisms and the possibility of electron delocalization as the ssDNA forms the duplex and becomes double-strand. The atomically flat surface, extremely small height (∼8 nm), and sharp tips of our nanoprisms display strong EM field enhancement near their surface and therefore are expected to be extremely sensitive to small changes of their local dielectric environment. (35, 40) Moreover, transformation of ssDNA into double-strand DNA significantly changes the refractive index because of the high charge density and polarizability of the DNAs. (52) The duplex DNA is capable of long-range charge transfer and alters the electron density around the nanoprisms thus influencing their LSPR properties. This interesting phenomenon requires further scientific study, which is currently under our investigation.
Our sensing mechanism is based on the hypothesis that the attachment of complementary target miRs to our plasmonic biosensor will shift the λLSPR to higher wavelength (Figure 1c). The total shift (ΔλLSPR) depended on the miR concentration (Figure 1d) and could be used to determine the limit of detection (LOD) (Figure 1e). The LODs calculated for miR-21 in three different media were found to be in the range of 23–35 fM, which was more than 1000 and 3 fold lower than with the label-free microring resonator (150 fmol) (15) and the nanopore based (100 fM) (16) miR sensors, respectively. Importantly, these techniques detected miRs in PBS buffer whereas we have demonstrated here for the first time a sensing approach in physiological media. Utilizing our same direct hybridization-based detection approach, plasmonic biosensors were constructed with of −C6-ssDNA-10, while keeping other parameters constant. The LOD for miR-10b in the above media was determined over a concentration range from 100 nM to 50 fM. The average ΔλLSPR and LODs for miR-10b in three diverse media are shown in Figure 2c.
The principle underlying the actions of plasmonic biosensors is based on the successful hybridization between miRs and ssDNA attached to nanoprisms, where a higher number of duplex formations will result in a larger change in the refractive index surrounding the nanoprisms resulting in larger ΔλLSPR and higher sensitivity. Therefore, it would be expected that functionalization of gold nanoprisms with 100% HS–C6-ssDNA-X (without the PEG6-thiol spacer) should reduce the LOD values because of steric hindrance and low attachment of miRs. To investigate this, gold nanoprisms were functionalized with 100% −C6-ssDNA-21 resulting in an ∼15.0 ± 1.8 nm λLSPR red shift (Figure 3a). The sensor was then incubated in different concentrations of miR-21 prepared in 40% human plasma. As illustrated in Figure 3a, an ∼9.6 ± 1.1 nm red shift was observed for a 100 nM miR-21 concentrations and the lowest concentration that can be repeatedly detected was 10 pM from a ΔλLSPR of 3.4 ± 0.5 nm. Figure 3b shows the ΔλLSPR versus concentration plot. Evidently, functionalization of the nanoprism’s surface with 100% −C6-ssDNA-21 resulted in a 200-fold increase in detection limit in comparison to the 1:1 ratio −C6-ssDNA-21/PEG6-SH mixed functionalization (Supporting Information Table S2). These experimental data further highlight our rationale for using spacers that increase the likelihood of hybridization. We believe fully covered gold nanoprisms were obtained when 100% −C6-ssDNA-21 was used for functionalization, which creates steric hindrance and does not allow the maximum number of miR-21 strands to come into close proximity with −C6-ssDNA-21 for hybridization. Therefore, not all the −C6-ssDNA-21 attached on the gold nanoprisms’ surface was hybridized with miR-21 strands resulting in low sensing response. Thus, if we introduce a spacer between the −C6-ssDNA-21, it will allow the maximum -ssDNA-21 strands to be freely available for hybridization without any interference and ultimately enhance the sensitivity of the biosensor. Accordingly, for the remaining of our investigation, we used a 1:1 mixed −C6-ssDNA-X:PEG6-SH to functionalize the gold nanoprisms.

Figure 3

Figure 3. Determining the optimum detection condition. (a) UV–visible extinction spectra monitoring the LSPR dipole peak (λLSPR) of gold nanoprisms attached to silanized glass substrate before (black, λLSPR = 796 nm) and after (red, λLSPR = 811 nm) functionalization with 1 μM of HS-C6-ssDNA-21 without PEG6-SH spacers and after incubation in 100 nM miR-21 solution in 40% human plasma (blue, λLSPR = 822 nm). (b) Average ΔλLSPR of these HS-C6-ssDNA-21 functionalized gold nanoprisms upon hybridization with different miR-21 concentrations in 40% human plasma. The ΔλLSPR were calculated by taking the difference between the λLSPR peak position of the nanoprisms after and before the incubation with miR-21 in PBS buffer.

In order to confirm the hybridization of miR-X with −C6-ssDNA-X that resulted in the ΔλLSPR, the enzyme RNase H was used to selectively cleave the DNA: RNA duplex and potentially reverse the ΔλLSPR. Initially, the plasmonic biosensor for miR-21 was incubated in a 100 nM solution of miR-21, which resulted in red-shift of λLSPR potentially reflecting hybridization. The biosensor was then immersed in 15 units of RNase H solution for 2 h. Afterward the λLSPR showed a blue shift and reverted back to its original position before miR-21 incubation (Figure 4a). When the 1:1 ratio −C6-ssDNA-21:PEG6-SH mixed functionalized biosensor was incubated with RNase H solution alone overnight, no noticeable change in λLSPR value was observed (Supporting Information Figure S7). These experimental results validate our previous observation that the λLSPR blue shift was due to the cleavage of heteroduplex done by RNase H. The biosensors were rinsed with RNase free water to PBS buffer and again incubated in 100 nM miR-21 solution for rehybridization where an ∼14 nm red shift of the λLSPR was observed. These experiments confirm our working hypothesis that hybridization between the nanoprism’s surface ligands (−C6-ssDNA-X) and the miR-X resulted in changes in the local dielectric environment around the nanoprisms causing wavelength shift. As shown in Figure 4b, the λLSPR responses were identical for several cycles due to hybridization and dehybridization of miR-21 over a period of 6 days. The same experiments were done for the miR-10b biosensor and similar results were observed, underscoring the long-term stability of the sensors and their potential for being developed into cost-effective point of care diagnostic tools.

Figure 4

Figure 4. Characterization of the plasmonic biosensors regeneration ability. (a) UV–visible extinction spectra of gold nanoprisms functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-21/PEG6-SH (red, λLSPR = 818 nm) attached to silanized glass, after incubation with 100 nM of miR-21 (blue, λLSPR = 832 nm), after treatment with 15 units of RNase H for 2 h (red dotted, λLSPR = 818 nm), and after rehybridized with 100 nM of miR-21 (blue dotted, λLSPR = 832 nm). (b) Changes in LSPR dipole peak position (λLSPR) of gold nanoprisms functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-21/PEG6-SH upon hybridization and dehybridization with miR-21 for several cycles. The λLSPR peak shifts back and forth upon sensor regeneration with RNase H by cleaving DNA/RNA duplex and rehybridization after incubation into 100 nM miR-21 in 40% human plasma. After each of the dehybridization steps, the plasmonic biosensors were thoroughly rinsed with PBS buffer to completely remove enzyme RNase H.

The hybridization takes place at the 5′ end of −C6-ssDNA-21 and the 3′ end of miR-21, which evidently increased the refractive index. Additionally such hybridization would also increase the thickness of the local dielectric environment of the nanoprisms. Together, a significantly large ΔλLSPR was generated for both miR-21 and miR-10b. Atomic force microscopy (AFM) analysis was conducted to characterize our plasmonic biosensors and also to verify the change in surface area caused by miR-21 incubation with mixed −C6-ssDNA-21 and PEG6-SH-functioanlized gold nanoprisms. After analyzing 40 different nanoprisms (Figure 5 and Supporting Information Figure S8) – the exact same area of four different sections of the sensor - an average 2.4 × 10–15 m2 increase in surface area was observed by AFM. Thus, attachment of miRs to plasmonic biosensors has increased the thickness of local dielectric environment around the gold nanoprisms and influenced their LSPR properties. Ultrasensitive refractive index-induced LSPR response of nanoprisms allows us to fabricate label-free plasmonic biosensor.

Figure 5

Figure 5. Surface characterization of the plasmonic biosensors. Atomic force microscopy images of gold nanoprisms bound to silanized glass substrate (a) after functionalization with 1:1 ratio of HS-C6-ssDNA-21/PEG6-SH (b) and after hybridization with100 nM miR-21 in 40% human plasma (c). The measurements were conducted in air. (d) Changes in the surface area of gold nanoprisms after each functionalization steps. Forty nanoprisms were selected to determine the average change in the surface area. Detailed method of surface area calculation is provided in the Supporting Information file.

The successful implementation of plasmonic biosensors for use with real biological samples mandates documentation of their specificity toward target miRs in that patient samples containing multiple miR species. The mix functionalized (−C6-ssDNA-21 and PEG6-SH) biosensors were incubated overnight in 40% human plasma solution containing 100 nM each of miR-16, miR-122, miR-126, and miR-141 because these miRs are commonly present in human plasma. The λLSPR response was measured before and after incubation (Supporting Information Figure S9) and resulted in an ∼2.5 ± 0.3 nm λLSPR red shift, which is within the instrument noise level and/or minor nonspecific adsorption of extraneous materials present in human plasma. In another control experiment, gold nanoprisms attached as before to glass substrate were functionalized with 100% PEG6-SH by incubation in a 1 μM aqueous solution, and after rinsing with large amounts of water, incubated in a 40% human plasma solution of 100 nM miR-21 for 12 h. This procedure resulted in only an ∼0.9 ± 0.7 nm λLSPR red shift (Supporting Information Figure S10), confirming that the plasmonic biosensors we designed are highly specific toward the target miRs.

Detection of miR Levels in in Plasma from Pancreatic Cancer Patients

Pancreatic cancer is the fourth-leading cause of cancer death in the United States with an annual mortality of nearly 40 000 and a dismal five-year survival rate of 6%. (1) PDAC is characterized by chemotherapeutic resistance and by the absence of an effective screening procedure for early disease. It is generally accepted that early diagnosis could reduce mortality rates substantially and thus a noninvasive early PDAC test must be developed. Several miRs (such as miR-21, -10b, -103, -155, -196a, 210, and -221) were found to be overexpressed in PDAC. (6-8, 53) Given their resistance to degradation, plasma miRs have the potential to serve as biomarkers for the noninvasive diagnosis of PDAC. Previously, nanopore sensors were used to detect miRs in lung cancer patients, but to the best of our knowledge no sensors have been developed to date to detect PDAC-related miRs in human plasma.
Utilizing our plasmonic biosensors we detected miR-21 and miR-10b in plasma from PDAC patients. Plasma samples were collected from six patients and six normal control subjects. Total plasma RNAs including miRs were extracted from 100 μL of each plasma sample using a TRIZOL kit with a final elution volume of 28 μL. Next, 14 μL volumes were used for miR quantification by the plasmonic biosensor and the remaining 14 μL were used in the qRT-PCR assay. The plasmonic biosensors were fabricated as described before for both miR-21 and miR-10b detection. The extracted human miR-21 or miR-10b samples were diluted in PBS buffer and incubated with the biosensors were for 12 h, followed by rinsing with PBS buffer and measurement of the λLSPR response in PBS buffer. The observed λLSPR shift for each miR-21 and miR-10b sample was converted into the corresponding concentration using the calibration curve derived for miR-21 or 10b under optimized conditions and compared with the value from normal control subjects (Figure 6a,c). The concentrations of miR-21 and miR-10b determined from plasmonic biosensors were also compared with the values obtained from the qRT-PCR assay (Figure 6b and Supporting Information Figure S16). Importantly, for the first time through a label-free technique we have shown that miR-10b concentration is nearly 4-fold higher than the miR-21 level in patient samples. Inasmuch as both miR-21 and miR-10b are overexpressed in PDAC, it is possible that miR-10b is released more efficiently by pancreatic cancer cells than miR-21, allowing it to achieve higher levels in the circulation. It is therefore possible that miR-10b levels are also increased within the pancreatic tumor microenvironment, where it could be acting to enhance PDAC biological aggressiveness.

Figure 6

Figure 6. Determination of microRNA concentration in PDAC patients and normal control subjects. (a) The average λLSPR peak shifts of gold nanoprisms functionalized with a 1:1 ratio of HS-C6-ssDNA-21/PEG6-SH upon hybridization with miR-21 from the total RNAs extracted from plasma samples of PDAC patients (blue diamonds) and normal control subjects (blue squares). The respective λLSPR peak shifts were converted to concentrations using the calibration curve established for miR-21 in PBS buffer as shown in Figure 2b [PDAC patients (red triangles), and for normal control subjects (red circles)]. (b) Comparison of miR-21 concentration for six PDAC patients determined using plasmonic biosensors (blue diamond) and qRT-PCR (red square). (c) Similar experiments were conducted to detect miR-10b where the λLSPR peak shifts and concentrations for PDAC patients are shown in blue diamonds and red triangles, respectively. The λLSPR peak shifts (blue squares) and concentrations (red circles) for normal controls are shown for comparison. (d) The average λLSPR peak shifts (blue diamonds) and concentration (red triangles) for the miR-21 in plasma samples from PDAC patients without any purification.

We also detected miR-21 levels directly in human plasma samples collected from PDAC patients without RNAs extraction. Thus, human plasma (50 μL/sample) from six pancreatic cancer patients were diluted in PBS buffer followed by incubation with our plasmonic biosensors for 12 h. The λLSPR response of each sample was measured through UV–vis spectroscopy and showed a steady increase in concentration from sample 6 to 1 (Figure 6d). Both plasmonic biosensor and qRT-PCR results indicated that miR-10b levels were higher in PDAC patients compared to normal control subjects and that the levels of miR-21 and miR-10b can be quantified with high accuracy using our gold nanoprism-based plasmonic biosensor without any modification, amplification, or labeling. Importantly, the miR-21 concentration in extracted samples was at least 2-fold lower than in the pure plasma samples. We believe this is due to loss of miRs during the RNA extraction process, which requires multiple steps for RNA purification. Therefore, the most widely used qRT-PCR method to determine the concentration of miRs in patients may not accurately represent the actual concentration. This limitation and imprecise quantification can be avoided by using our newly developed plasmonic biosensors, which can provide a unique opportunity as potential diagnostic and prognostic markers in PDAC, other cancers, and potentially other disease states.

Conclusion

We have designed, fabricated, and characterized a plasmonic biosensor that was able to detect PDAC relevant miRs in human plasma without using RNAs extraction, which opens a new avenue for the direct detection and quantification of miR levels in clinical samples without any form of sample preparation. To our knowledge, this is the first LSPR-based, label-free, direct hybridization method for miR detection, which eliminates all the current drawbacks such as labeling, tagging, amplification, use of highly toxic chemical, and further modification of the sensor. Furthermore, it vastly simplifies the detection approach without requiring detailed knowledge of the electron or energy transfer processes involved as in other more complicated techniques. Additionally, this ultrasensitive, plasmonic-based, direct hybridization-controlled detection approach is applicable to any type of miRs that are relevant to various diseases. It was found that our plasmonic biosensor can be regenerated through several cycles and is stable for several days without compromising its sensitivity and selectivity, which should enable the development of simple, cost-effective tools for the early detection of miRs and thus facilitate the early diagnosis of various cancers. Finally, the large EM-field enhancement at the nanoprism’s sharp tips (39) will enhance the Raman scattering intensity of the analytes. In theory, therefore, nanoprisms can be used to design effective substrates for surface-enhanced Raman spectroscopy-based (54-57) detection and quantification of multiple miRs simultaneously through integration of their spectral characteristic with the λLSPR shifts.

Materials and Methods

All synthetic DNA probes and microRNAs were purchased from Sigma-Aldrich (U.S.A.). PBS buffer prepared with RNase-free water was used to dilute oligonucleotides and miRs solutions. Patient plasma was obtained from the Indiana University Simon Cancer Center Solid Tissue Bank (Indianapolis, Indiana).

Fabrication of LSPR-Based miR Sensors and Detection

The gold nanoprism-based miR sensors were designed using our published procedure with modification. (49) The attachment of gold nanoprisms on silanized glass substrates is described in the Supporting Information file. The substrate-bound nanoprisms were incubated in PBS buffer solution containing 1 μM each of HS–C6-ssDNA-X and PEG6-SH overnight and rinsed with PBS buffer. The initial LSPR peak position of each sensing platform was determined using UV–visible spectroscopy in PBS buffer and then was incubated in the different concentrations of miR solutions, for exmaple, either in PBS buffer, 40% bovine plasma, or 40% human plasma for 12 h at room temperature. The plasmonic biosensors were thoroughly washed with PBS buffer to remove any nonspecifically adsorbed species. The miR bound biosensor was then placed in PBS buffer for 10 min before the LSPR peak position was determined. For UV–vis extinction spectra measurement, one particular solvent was chosen to avoid the solvent dielectric constant effect, which is known to shift the LSPR peak. (21, 58, 59)

Total RNA Extraction and Quantification of MicroRNA by qRT-PCR

Total RNA was isolated from plasma samples that were obtained from the Indiana University Simon Cancer Center Solid Tissue Bank (Indianapolis, IN, U.S.A.) using Trizol-LS reagent (Life Technologies, Carlsbad, CA, U.S.A.). cDNA was generated using 10 ng of RNA and miR-10b, miR-21, or miR-425–5p RT primers and a miR reverse transcription kit (Life Technologies) as per the manufacturer’s recommendations. Quantitative PCR (qPCR) was performed using Taqman miR expression assay reagents. Expression levels as determined by qPCR were normalized to miR-425-5p, since this miR was expressed at similar levels in all samples and exhibited <1 cycle threshold (Ct) difference across all samples. After normalization to miR-425-5p (ΔCt), the ΔCt values for miRs in controls were averaged and subtracted from the ΔCt values of each individual sample (ΔΔCt). miR levels were then calculated using the 2–ΔΔCt method. (60)

Supporting Information

Click to copy section linkSection link copied!

Experimental detail of nanoprisms synthesis, fabrication of plasmonic biosensors, and additional UV–visible spectra, AFM images, and histograms. This material is available free of charge via the Internet at http://pubs.acs.org.

Terms & Conditions

Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

Author Information

Click to copy section linkSection link copied!

  • Corresponding Authors
    • Murray Korc - Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United States‡Department of Medicine, §Department of Biochemistry and Molecular Biology, and ∥the Center for Pancreatic Cancer Research at the IU Simon Cancer Center, Indiana University School of Medicine, 980 W. Walnut Street, C549, Indianapolis, Indiana 46202, United StatesDepartment of Physics, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United StatesIntegrated Nanosystems Development Institute, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, Indianapolis, Indiana 46202, United States Email: [email protected]
    • Rajesh Sardar - Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United StatesIntegrated Nanosystems Development Institute, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, Indianapolis, Indiana 46202, United States Email: [email protected]
  • Authors
    • Gayatri K. Joshi - Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United States
    • Samantha Deitz-McElyea - Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United States‡Department of Medicine, §Department of Biochemistry and Molecular Biology, and ∥the Center for Pancreatic Cancer Research at the IU Simon Cancer Center, Indiana University School of Medicine, 980 W. Walnut Street, C549, Indianapolis, Indiana 46202, United StatesDepartment of Physics, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United StatesIntegrated Nanosystems Development Institute, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, Indianapolis, Indiana 46202, United States
    • Merrell Johnson - Department of Physics, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United States
    • Sonali Mali - Department of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, 402 N. Blackford Street, LD 326, Indianapolis, Indiana 46202, United States
  • Notes
    The authors declare no competing financial interest.

Acknowledgment

Click to copy section linkSection link copied!

The authors would like to thank B. Muhoberac and S. Savant for invaluable advice regarding the manuscript and K. Lawrence for providing PEG6-thiol. We also thank the IUSCC Cancer Center at Indiana University School of Medicine for the use of the Tissue Procurement and Distribution Core, which provided patient and control plasma samples for microRNA assays. The research was partially supported by Indiana University-Purdue University Indianapolis startup funds (R.S), Purdue Research Foundation (R.S), the Indiana Economic Development Fund (IEDF) and the National Institute of Health Grant R37-CA-075059 (M.K). The authors also thank Amy Trotch (from Affymetrix) for providing RNase H sample and the Wallace lab (IUPUI) for the use of the AFM instrument. S.M. thanks ACS Project SEED program for financial support.

References

Click to copy section linkSection link copied!

This article references 60 other publications.

  1. 1
    Siegel, R.; Ma, J.; Zou, Z.; Jemal, A. Ca: Cancer J. Clin. 2014, 64, 9 29
  2. 2
    Bartel, D. P. Cell 2004, 116, 281 297
  3. 3
    Winter, J.; Jung, S.; Keller, S.; Gregory, R. I.; Diederichs, S. Nat. Cell Biol. 2009, 11, 228 234
  4. 4
    Esquela-Kerscher, A.; Slack, F. J. Nat. Rev. Cancer 2006, 6, 259 269
  5. 5
    He, L.; Thomson, J. M.; Hemann, M. T.; Hernando-Monge, E.; Mu, D.; Goodson, S.; Powers, S.; Cordon-Cardo, C.; Lowe, S. W.; Hannon, G. J.; Hammond, S. M. Nature 2005, 435, 828 833
  6. 6
    Szafranska, A. E.; Doleshal, M.; Edmunds, H. S.; Gordon, S.; Luttges, J.; Munding, J. B.; Barth, R. J.; Gutmann, E. J.; Suriawinata, A. A.; Marc Pipas, J.; Tannapfel, A.; Korc, M.; Hahn, S. A.; Labourier, E.; Tsongalis, G. J. Clin. Chem. 2008, 54, 1716 1724
  7. 7
    Setoyama, T.; Zhang, X.; Natsugoe, S.; Calin, G. A. Clin. Cancer Res. 2011, 17, 5527 5529
  8. 8
    Ouyang, H.; Gore, J.; Deitz, S.; Korc, M. Oncogene 2014, 33, 4664 4674
  9. 9
    Fang, S.; Lee, H. J.; Wark, A. W.; Corn, R. M. J. Am. Chem. Soc. 2006, 128, 14044 14046
  10. 10
    Li, J.; Yao, B.; Huang, H.; Wang, Z.; Sun, C.; Fan, Y.; Chang, Q.; Li, S.; Wang, X.; Xi, J. Anal. Chem. 2009, 81, 5446 5451
  11. 11
    Chen, C.; Ridzon, D. A.; Broomer, A. J.; Zhou, Z.; Lee, D. H.; Nguyen, J. T.; Barbisin, M.; Xu, N. L.; Mahuvakar, V. R.; Andersen, M. R.; Lao, K. Q.; Livak, K. J.; Guegler, K. J. Nucleic Acids Res. 2005, 33, e179
  12. 12
    Johnson, B. N.; Mutharasan, R. Anal. Chem. 2012, 84, 10426 10436
  13. 13
    Ramnani, P.; Gao, Y.; Ozsoz, M.; Mulchandani, A. Anal. Chem. 2013, 85, 8061 8064
  14. 14
    Cissell, K. A.; Rahimi, Y.; Shrestha, S.; Hunt, E. A.; Deo, S. K. Anal. Chem. 2008, 80, 2319 2325
  15. 15
    Qavi, A. J.; Bailey, R. C. Angew. Chem., Int. Ed. 2010, 49, 4608 4611
  16. 16
    Wang, Y.; Zheng, D.; Tan, Q.; Wang, M. X.; Gu, L.-Q. Nat. Nanotechnol. 2011, 6, 668 674
  17. 17
    Wanunu, M.; Dadosh, T.; Ray, V.; Jin, J.; McReynolds, L.; Drndic, M. Nat. Nanotechnol. 2010, 5, 807 814
  18. 18
    Lee, H.; Park, J.-E.; Nam, J.-M. Nat. Commun. 2014, 5, 1 7
  19. 19
    Jain, P. K.; Huang, X.; El-Sayed, I. H.; El-Sayed, M. A. Acc. Chem. Res. 2008, 41, 1578 1586
  20. 20
    Halas, N. J.; Lal, S.; Chang, W.-S.; Link, S.; Nordlander, P. Chem. Rev. 2011, 111, 3913 3961
  21. 21
    Mayer, K. M.; Hafner, J. H. Chem. Rev. 2011, 111, 3828 3857
  22. 22
    Jin, R.; Cao, Y.; Mirkin, C. A.; Kelly, K. L.; Schatz, G. C.; Zheng, J. G. Science 2001, 294, 1901 1903
  23. 23
    Sun, Y.; Xia, Y. Science 2002, 298, 2176 2179
  24. 24
    Anker, J. N.; Hall, W. P.; Lyandres, O.; Shah, N. C.; Zhao, J.; Van Duyne, R. P. Nat. Mater. 2008, 7, 442 453
  25. 25
    Weiss, P. S. Acc. Chem. Res. 2008, 41, 1772 1781
  26. 26
    Yan, Y.; Chen, J. I. L.; Ginger, D. S. Nano Lett. 2012, 12, 2530 2536
  27. 27
    Saha, K.; Agasti, S. S.; Kim, C.; Li, X.; Rotello, V. M. Chem. Rev. 2012, 112, 2739 2779
  28. 28
    Stewart, M. E.; Anderton, C. R.; Thompson, L. B.; Maria, J.; Gray, S. K.; Rogers, J. A.; Nuzzo, R. G. Chem. Rev. 2008, 108, 494 521
  29. 29
    Beeram, S. R.; Zamborini, F. P. J. Am. Chem. Soc. 2009, 131, 11689 11691
  30. 30
    Chen, S.; Svedendahl, M.; Duyne, R. P. V.; Käll, M. Nano Lett. 2011, 11, 1826 1830
  31. 31
    Chen, Y.; Munechika, K.; Ginger, D. S. Nano Lett. 2007, 7, 690 696
  32. 32
    Haes, A. J.; Hall, W. P.; Chang, L.; Klein, W. L.; Van Duyne, R. P. Nano Lett. 2004, 4, 1029 1034
  33. 33
    Stranahan, S. M.; Willets, K. A. Nano Lett. 2010, 10, 3777 3784
  34. 34
    Elghanian, R.; Storhoff, J. J.; Mucic, R. C.; Letsinger, R. L.; Mirkin, C. A. Science 1997, 277, 1078 1081
  35. 35
    Willets, K. A.; Van Duyne, R. P. Annu. Rev. Phys. Chem. 2007, 58, 267 297
  36. 36
    Malinsky, M. D.; Kelly, K. L.; Schatz, G. C.; Van Duyne, R. P. J. Am. Chem. Soc. 2001, 123, 1471 1482
  37. 37
    Nusz, G. J.; Curry, A. C.; Marinakos, S. M.; Wax, A.; Chilkoti, A. ACS Nano 2009, 3, 795 806
  38. 38
    Jackson, J. B.; Westcott, S. L.; Hirsch, L. R.; West, J. L.; Halas, N. J. Appl. Phys. Lett. 2003, 82, 257 259
  39. 39
    Hao, E.; Schatz, G. C. J. Chem. Phys. 2004, 120, 357 366
  40. 40
    Sherry, L. J.; Jin, R.; Mirkin, C. A.; Schatz, G. C.; Van Duyne, R. P. Nano Lett. 2006, 6, 2060 2065
  41. 41
    Chen, H.; Shao, L.; Woo, K. C.; Ming, T.; Lin, H.-Q.; Wang, J. J. Phys. Chem. C 2009, 113, 17691 17697
  42. 42
    Joshi, G. K.; McClory, P. J.; Muhoberac, B. B.; Kumbhar, A.; Smith, K. A.; Sardar, R. J. Phys. Chem. C 2012, 116, 20990 21000
  43. 43
    Joshi, G. K.; McClory, P. J.; Dolai, S.; Sardar, R. J. Mater. Chem. 2012, 22, 923 931
  44. 44
    Haes, A. J.; Zou, S.; Zhao, J.; Schatz, G. C.; Van Duyne, R. P. J. Am. Chem. Soc. 2006, 128, 10905 10914
  45. 45
    Hall, W. P.; Modica, J.; Anker, J.; Lin, Y.; Mrksich, M.; Van Duyne, R. P. Nano Lett. 2011, 11, 1098 1105
  46. 46
    McFarland, A. D.; Van Duyne, R. P. Nano Lett. 2003, 3, 1057 1062
  47. 47
    Bain, C. D.; Whitesides, G. M. J. Am. Chem. Soc. 1989, 111, 7164 7175
  48. 48
    Murphy, C. J.; Gole, A. M.; Stone, J. W.; Sisco, P. N.; Alkilany, A. M.; Goldsmith, E. C.; Baxter, S. C. Acc. Chem. Res. 2008, 41, 1721 1730
  49. 49
    Joshi, G. K.; Blodgett, K. N.; Muhoberac, B. B.; Johnson, M. A.; Smith, K. A.; Sardar, R. Nano Lett. 2014, 14, 532 540
  50. 50
    Preis, M.; Gardner, T. B.; Gordon, S. R.; Pipas, J. M.; Mackenzie, T. A.; Klein, E. E.; Longnecker, D. S.; Gutmann, E. J.; Sempere, L. F.; Korc, M. Clin. Cancer Res. 2011, 17, 5812 5821
  51. 51
    Sempere, L. F.; Preis, M.; Yezefski, T.; Ouyang, H.; Suriawinata, A. A.; Silahtaroglu, A.; Conejo-Garcia, J. R.; Kauppinen, S.; Wells, W.; Korc, M. Clin. Cancer Res. 2010, 16, 4246 4255
  52. 52
    Elhadj, S.; Singh, G.; Saraf, R. F. Langmuir 2004, 20, 5539 5543
  53. 53
    Greither, T.; Grochola, L. F.; Udelnow, A.; Lautenschläger, C.; Würl, P.; Taubert, H. Int. J. Cancer 2010, 126, 73 80
  54. 54
    Stiles, P. L.; Dieringer, J. A.; Shah, N. C.; Van Duyne, R. P. Annu. Rev. Anal. Chem. 2008, 1, 601 626
  55. 55
    Moskovits, M. J. Raman Spectrosc. 2005, 36, 485 496
  56. 56
    Singh, A. K.; Khan, S. A.; Fan, Z.; Demeritte, T.; Senapati, D.; Kanchanapally, R.; Ray, P. C. J. Am. Chem. Soc. 2012, 134, 8662 8669
  57. 57
    Jackson, J. B.; Halas, N. J. Proc. Nat. Acad. Sci. U.S.A. 2004, 101, 17930 17935
  58. 58
    Otte, M. A.; Sepulveda, B.; Ni, W.; Juste, J. P.; Liz-Marzan, L. M.; Lechuga, L. M. ACS Nano 2009, 4, 349 357
  59. 59
    Novo, C.; Funston, A. M.; Mulvaney, P. Nat. Nanotechnol. 2008, 3, 598 602
  60. 60
    Livak, K. J.; Schmittgen, T. D. Methods 2001, 25, 402 408

Cited By

Click to copy section linkSection link copied!

This article is cited by 125 publications.

  1. Chang-Chieh Hsu, Yunchen Yang, Eric Kannisto, Xie Zeng, Guan Yu, Santosh K. Patnaik, Grace K. Dy, Mary E. Reid, Qiaoqiang Gan, Yun Wu. Simultaneous Detection of Tumor Derived Exosomal Protein–MicroRNA Pairs with an Exo-PROS Biosensor for Cancer Diagnosis. ACS Nano 2023, 17 (9) , 8108-8122. https://doi.org/10.1021/acsnano.2c10970
  2. Adrianna N. Masterson, Nayela N. Chowdhury, Yue Fang, Michele T. Yip-Schneider, Sumon Hati, Prashant Gupta, Sha Cao, Huangbing Wu, C. Max Schmidt, Melissa L. Fishel, Rajesh Sardar. Amplification-Free, High-Throughput Nanoplasmonic Quantification of Circulating MicroRNAs in Unprocessed Plasma Microsamples for Earlier Pancreatic Cancer Detection. ACS Sensors 2023, 8 (3) , 1085-1100. https://doi.org/10.1021/acssensors.2c02105
  3. Adrianna N. Masterson, Rajesh Sardar. Selective Detection and Ultrasensitive Quantification of SARS-CoV-2 IgG Antibodies in Clinical Plasma Samples Using Epitope-Modified Nanoplasmonic Biosensing Platforms. ACS Applied Materials & Interfaces 2022, 14 (23) , 26517-26527. https://doi.org/10.1021/acsami.2c06599
  4. Thakshila Liyanage, Bayan Alharbi, Linh Quan, Aurora Esquela-Kerscher, Gymama Slaughter. Plasmonic-Based Biosensor for the Early Diagnosis of Prostate Cancer. ACS Omega 2022, 7 (2) , 2411-2418. https://doi.org/10.1021/acsomega.1c06479
  5. Sumon Hati, Sarah R. Langlais, Adrianna N. Masterson, Thakshila Liyanage, Barry B. Muhoberac, Hristos Kaimakliotis, Merrell Johnson, Rajesh Sardar. Photoswitchable Machine-Engineered Plasmonic Nanosystem with High Optical Response for Ultrasensitive Detection of microRNAs and Proteins Adaptively. Analytical Chemistry 2021, 93 (41) , 13935-13944. https://doi.org/10.1021/acs.analchem.1c02990
  6. Duoduo Zhang, Kan Wang, Wei Wei, Yong Liu, Songqin Liu. Multifunctional Plasmonic Core-Satellites Nanoprobe for Cancer Diagnosis and Therapy Based on a Cascade Reaction Induced by MicroRNA. Analytical Chemistry 2021, 93 (27) , 9521-9530. https://doi.org/10.1021/acs.analchem.1c01539
  7. Adrianna N. Masterson, Barry B. Muhoberac, Adnan Gopinadhan, David J. Wilde, Frédérique T. Deiss, Chandy C. John, Rajesh Sardar. Multiplexed and High-Throughput Label-Free Detection of RNA/Spike Protein/IgG/IgM Biomarkers of SARS-CoV-2 Infection Utilizing Nanoplasmonic Biosensors. Analytical Chemistry 2021, 93 (25) , 8754-8763. https://doi.org/10.1021/acs.analchem.0c05300
  8. Hui Hong Yan, Qiang Zhang, Ru Cheng, Fu Zhu, Jia Jun Liu, Peng Fei Gao, Hong Yan Zou, Gao Lin Liang, Cheng Zhi Huang, Jian Wang. Size-Dependent Plasmonic Resonance Scattering Characteristics of Gold Nanorods for Highly Sensitive Detection of microRNA-27a. ACS Applied Bio Materials 2021, 4 (4) , 3469-3475. https://doi.org/10.1021/acsabm.1c00029
  9. Pawel L. Urban. Please Avoid Plotting Analytical Response against Logarithm of Concentration. Analytical Chemistry 2020, 92 (15) , 10210-10212. https://doi.org/10.1021/acs.analchem.0c02096
  10. Adrianna N. Masterson, Thakshila Liyanage, Hristos Kaimakliotis, Hamed Gholami Derami, Frédérique Deiss, Rajesh Sardar. Bottom-Up Fabrication of Plasmonic Nanoantenna-Based High-throughput Multiplexing Biosensors for Ultrasensitive Detection of microRNAs Directly from Cancer Patients’ Plasma. Analytical Chemistry 2020, 92 (13) , 9295-9304. https://doi.org/10.1021/acs.analchem.0c01639
  11. Gyanaranjan Prusty, Jacob T. Lee, Soenke Seifert, Barry B. Muhoberac, Rajesh Sardar. Ultrathin Plasmonic Tungsten Oxide Quantum Wells with Controllable Free Carrier Densities. Journal of the American Chemical Society 2020, 142 (13) , 5938-5942. https://doi.org/10.1021/jacs.9b13909
  12. Thakshila Liyanage, Malpuri Nagaraju, Merrell Johnson, Barry B. Muhoberac, Rajesh Sardar. Reversible Tuning of the Plasmoelectric Effect in Noble Metal Nanostructures Through Manipulation of Organic Ligand Energy Levels. Nano Letters 2020, 20 (1) , 192-200. https://doi.org/10.1021/acs.nanolett.9b03588
  13. Xiao Ying Gu, Jia Jun Liu, Peng Fei Gao, Yuan Fang Li, Cheng Zhi Huang. Gold Triangular Nanoplates Based Single-Particle Dark-Field Microscopy Assay of Pyrophosphate. Analytical Chemistry 2019, 91 (24) , 15798-15803. https://doi.org/10.1021/acs.analchem.9b04093
  14. Deniz Umut Yildirim, Amir Ghobadi, Mahmut Can Soydan, Murat Gokbayrak, Ahmet Toprak, Bayram Butun, Ekmel Ozbay. Colorimetric and Near-Absolute Polarization-Insensitive Refractive-Index Sensing in All-Dielectric Guided-Mode Resonance Based Metasurface. The Journal of Physical Chemistry C 2019, 123 (31) , 19125-19134. https://doi.org/10.1021/acs.jpcc.9b04748
  15. Jisun Ki, Hyo young Lee, Hye Young Son, Yong-Min Huh, Seungjoo Haam. Sensitive Plasmonic Detection of miR-10b in Biological Samples Using Enzyme-Assisted Target Recycling and Developed LSPR Probe. ACS Applied Materials & Interfaces 2019, 11 (21) , 18923-18929. https://doi.org/10.1021/acsami.9b03005
  16. Xiao-Ping Zhao, Fei-Fei Liu, Wen-Chao Hu, Muhammad Rizwan Younis, Chen Wang, Xing-Hua Xia. Biomimetic Nanochannel-Ionchannel Hybrid for Ultrasensitive and Label-Free Detection of MicroRNA in Cells. Analytical Chemistry 2019, 91 (5) , 3582-3589. https://doi.org/10.1021/acs.analchem.8b05536
  17. Thakshila Liyanage, Adrianna N. Masterson, Hector H. Oyem, Hristos Kaimakliotis, Hang Nguyen, Rajesh Sardar. Plasmoelectronic-Based Ultrasensitive Assay of Tumor Suppressor microRNAs Directly in Patient Plasma: Design of Highly Specific Early Cancer Diagnostic Technology. Analytical Chemistry 2019, 91 (3) , 1894-1903. https://doi.org/10.1021/acs.analchem.8b03768
  18. Li Zhang, Xuemeng Li, Yangyang Wang, Kang Sun, Xuexian Chen, Huanjun Chen, Jianhua Zhou. Reproducible Plasmonic Nanopyramid Array of Various Metals for Highly Sensitive Refractometric and Surface-Enhanced Raman Biosensing. ACS Omega 2018, 3 (10) , 14181-14187. https://doi.org/10.1021/acsomega.7b02016
  19. Jingyi Luan, Ting Xu, John Cashin, Jeremiah J. Morrissey, Evan D. Kharasch, Srikanth Singamaneni. Environmental Stability of Plasmonic Biosensors Based on Natural versus Artificial Antibody. Analytical Chemistry 2018, 90 (13) , 7880-7887. https://doi.org/10.1021/acs.analchem.7b05470
  20. Arif E. Cetin, Pinar Iyidogan, Yuki Hayashi, Mark Wallen, Kandaswamy Vijayan, Eugene Tu, Michael Nguyen, Arnold Oliphant. Plasmonic Sensor Could Enable Label-Free DNA Sequencing. ACS Sensors 2018, 3 (3) , 561-568. https://doi.org/10.1021/acssensors.7b00957
  21. Ying Zhang, Zhenhua Shuai, Hao Zhou, Zhimin Luo, Bing Liu, Yinan Zhang, Lei Zhang, Shufen Chen, Jie Chao, Lixing Weng, Quli Fan, Chunhai Fan, Wei Huang, Lianhui Wang. Single-Molecule Analysis of MicroRNA and Logic Operations Using a Smart Plasmonic Nanobiosensor. Journal of the American Chemical Society 2018, 140 (11) , 3988-3993. https://doi.org/10.1021/jacs.7b12772
  22. Kan Wang, Li Shangguan, Yuanjian Liu, Ling Jiang, Fen Zhang, Yuanqing Wei, Yuanjian Zhang, Zhengjian Qi, Kang Wang, and Songqin Liu . In Situ Detection and Imaging of Telomerase Activity in Cancer Cell Lines via Disassembly of Plasmonic Core–Satellites Nanostructured Probe. Analytical Chemistry 2017, 89 (13) , 7262-7268. https://doi.org/10.1021/acs.analchem.7b01882
  23. Pedro M. R. Paulo, Peter Zijlstra, Michel Orrit, Emilio Garcia-Fernandez, Tamara C. S. Pace, Ana S. Viana, and Sílvia M. B. Costa . Tip-Specific Functionalization of Gold Nanorods for Plasmonic Biosensing: Effect of Linker Chain Length. Langmuir 2017, 33 (26) , 6503-6510. https://doi.org/10.1021/acs.langmuir.7b00422
  24. Zachary S. Ballard, Daniel Shir, Aashish Bhardwaj, Sarah Bazargan, Shyama Sathianathan, and Aydogan Ozcan . Computational Sensing Using Low-Cost and Mobile Plasmonic Readers Designed by Machine Learning. ACS Nano 2017, 11 (2) , 2266-2274. https://doi.org/10.1021/acsnano.7b00105
  25. Jean-Francois Masson . Surface Plasmon Resonance Clinical Biosensors for Medical Diagnostics. ACS Sensors 2017, 2 (1) , 16-30. https://doi.org/10.1021/acssensors.6b00763
  26. Amit Kumar, Sungi Kim, and Jwa-Min Nam . Plasmonically Engineered Nanoprobes for Biomedical Applications. Journal of the American Chemical Society 2016, 138 (44) , 14509-14525. https://doi.org/10.1021/jacs.6b09451
  27. Gayatri K. Joshi, Sarah L. White, Merrell A. Johnson, Rajesh Sardar, and Prashant K. Jain . Ultrashort, Angstrom-Scale Decay of Surface-Enhanced Raman Scattering at Hot Spots. The Journal of Physical Chemistry C 2016, 120 (43) , 24973-24981. https://doi.org/10.1021/acs.jpcc.6b08242
  28. César S. Huertas, David Fariña, and Laura M. Lechuga . Direct and Label-Free Quantification of Micro-RNA-181a at Attomolar Level in Complex Media Using a Nanophotonic Biosensor. ACS Sensors 2016, 1 (6) , 748-756. https://doi.org/10.1021/acssensors.6b00162
  29. Si Li, Liguang Xu, Wei Ma, Xiaoling Wu, Maozhong Sun, Hua Kuang, Libing Wang, Nicholas A. Kotov, and Chuanlai Xu . Dual-Mode Ultrasensitive Quantification of MicroRNA in Living Cells by Chiroplasmonic Nanopyramids Self-Assembled from Gold and Upconversion Nanoparticles. Journal of the American Chemical Society 2016, 138 (1) , 306-312. https://doi.org/10.1021/jacs.5b10309
  30. Richard M. Graybill and Ryan C. Bailey . Emerging Biosensing Approaches for microRNA Analysis. Analytical Chemistry 2016, 88 (1) , 431-450. https://doi.org/10.1021/acs.analchem.5b04679
  31. Gayatri K. Joshi, Samantha Deitz-McElyea, Thakshila Liyanage, Katie Lawrence, Sonali Mali, Rajesh Sardar, and Murray Korc . Label-Free Nanoplasmonic-Based Short Noncoding RNA Sensing at Attomolar Concentrations Allows for Quantitative and Highly Specific Assay of MicroRNA-10b in Biological Fluids and Circulating Exosomes. ACS Nano 2015, 9 (11) , 11075-11089. https://doi.org/10.1021/acsnano.5b04527
  32. Peng Miao, Bidou Wang, Fanyu Meng, Jian Yin, and Yuguo Tang . Ultrasensitive Detection of MicroRNA through Rolling Circle Amplification on a DNA Tetrahedron Decorated Electrode. Bioconjugate Chemistry 2015, 26 (3) , 602-607. https://doi.org/10.1021/acs.bioconjchem.5b00064
  33. Shahram Bahadori-Haghighi, Mohsen Heidari, Mohsen Katebi Jahromi. Graphene-Dielectric metasurface of asymmetric grooved disks for biosensing and surface roughness evaluation. Optics & Laser Technology 2024, 176 , 110962. https://doi.org/10.1016/j.optlastec.2024.110962
  34. Shivani Singla, Muskan, Basant Lal, Jatinder Kaur, Gopi Sharma. Optical behavior of glasses containing gold nanoparticles: A review. Optics & Laser Technology 2024, 174 , 110675. https://doi.org/10.1016/j.optlastec.2024.110675
  35. Samar Moustafa, Jamal Q. M. Almarashi, Mohamed K. Zayed, Mohamed Almokhtar, Mohamed Rashad, Hesham Fares. Plasmon resonances of GZO core–Ag shell nanospheres, nanorods, and nanodisks for biosensing and biomedical applications in near-infrared biological windows I and II. Physical Chemistry Chemical Physics 2024, 26 (25) , 17817-17829. https://doi.org/10.1039/D4CP00817K
  36. Ben-Xin Wang, Guiyuan Duan, Wei Xu, Chongyang Xu, Jieying Jiang, Zhuchuang Yang, Yangkuan Wu, Fuwei Pi. Flexible surface-enhanced Raman scatting substrates: recent advances in their principles, design strategies, diversified material selections and applications. Critical Reviews in Food Science and Nutrition 2024, 64 (2) , 472-516. https://doi.org/10.1080/10408398.2022.2106547
  37. Shalini Preethi P., Sindhu V., Karthik Sambath, Arun Reddy Ravula, Geetha Palani, Sivakumar Vijayaraghavalu, Shanmuga Sundari I., Venkatesan Perumal. Recent advances in nanocarriers for pancreatic cancer therapy. 2024, 169-211. https://doi.org/10.1016/B978-0-443-19142-8.00004-8
  38. Jack Hu, Fareeha Safir, Kai Chang, Sahil Dagli, Halleh B. Balch, John M. Abendroth, Jefferson Dixon, Parivash Moradifar, Varun Dolia, Malaya K. Sahoo, Benjamin A. Pinsky, Stefanie S. Jeffrey, Mark Lawrence, Jennifer A. Dionne. Rapid genetic screening with high quality factor metasurfaces. Nature Communications 2023, 14 (1) https://doi.org/10.1038/s41467-023-39721-w
  39. Yuye Wang, Yurui Hu, Ruibin Xie, Qi Zeng, Yanhang Hong, Xi Chen, Pengcheng Zhang, Lin Zeng, Yi Zhang, Shuwen Zeng, Hui Yang. Ultrasensitive label-free miRNA-21 detection based on MXene-enhanced plasmonic lateral displacement measurement. Nanophotonics 2023, 12 (21) , 4055-4062. https://doi.org/10.1515/nanoph-2023-0432
  40. Tyler Hertenstein, Yisha Tang, Alexander S. Day, Jocelyn Reynolds, Patrick V. Viboolmate, Jeong-Yeol Yoon. Rapid and sensitive detection of miRNA via light scatter-aided emulsion-based isothermal amplification using a custom low-cost device. Biosensors and Bioelectronics 2023, 237 , 115444. https://doi.org/10.1016/j.bios.2023.115444
  41. Dang Du Nguyen, Seho Lee, Inki Kim. Recent Advances in Metaphotonic Biosensors. Biosensors 2023, 13 (6) , 631. https://doi.org/10.3390/bios13060631
  42. Kang Yang, Yan Chen, Sen Yan, Wenxing Yang. Nanostructured surface plasmon resonance sensors: Toward narrow linewidths. Heliyon 2023, 9 (6) , e16598. https://doi.org/10.1016/j.heliyon.2023.e16598
  43. Namita Sharma, Sudha Srivastava. miRNA 143 based nanobiosensor to diagnose pancreatic cancer. Materials Today: Proceedings 2023, 18 https://doi.org/10.1016/j.matpr.2023.04.461
  44. José Manuel Costa-Fernández, Candela Melendreras García, Ana Soldado. Optical Sensors in Medical Diagnosis. 2023, 297-316. https://doi.org/10.1016/B978-0-12-822548-6.00153-9
  45. Muhammad Javed Iqbal, Zeeshan Javed, Jesús Herrera-Bravo, Haleema Sadia, Faiza Anum, Shahid Raza, Arifa Tahir, Muhammad Naeem Shahwani, Javad Sharifi-Rad, Daniela Calina, William C. Cho. Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation. Cancer Cell International 2022, 22 (1) https://doi.org/10.1186/s12935-022-02777-7
  46. Samantha Bordy, Jiuk Byun, Lisa V Poulikakos. Nanophotonic materials: enabling targeted cancer diagnostics and therapeutics with light. Current Opinion in Chemical Engineering 2022, 37 , 100852. https://doi.org/10.1016/j.coche.2022.100852
  47. Valeria Nocerino, Bruno Miranda, Chiara Tramontano, Giovanna Chianese, Principia Dardano, Ilaria Rea, Luca De Stefano. Plasmonic Nanosensors: Design, Fabrication, and Applications in Biomedicine. Chemosensors 2022, 10 (5) , 150. https://doi.org/10.3390/chemosensors10050150
  48. Abdelmonaim Azzouz, Lamia Hejji, Ki-Hyun Kim, Deepak Kukkar, Badredine Souhail, Neha Bhardwaj, Richard J.C. Brown, Wei Zhang. Advances in surface plasmon resonance–based biosensor technologies for cancer biomarker detection. Biosensors and Bioelectronics 2022, 197 , 113767. https://doi.org/10.1016/j.bios.2021.113767
  49. Irene Fernandez-Cuesta, Andreu Llobera, María Ramos-Payán. Optofluidic systems enabling detection in real samples: A review. Analytica Chimica Acta 2022, 1192 , 339307. https://doi.org/10.1016/j.aca.2021.339307
  50. Mohammad Salemizadeh Parizi, Fatemeh Salemizadehparizi, Mahdi Molaei Zarasvand, Saeed Abdolhosseini, Shahram Bahadori-Haghighi, Alireza Khalilian. High-Performance Graphene-Based Biosensor Using a Metasurface of Asymmetric Silicon Disks. IEEE Sensors Journal 2022, 22 (3) , 2037-2044. https://doi.org/10.1109/JSEN.2021.3134205
  51. Fariba Mollarasouli, Sonia Bahrani. Low-molecular-weight biomarkers: types and detection strategies. 2022, 23-69. https://doi.org/10.1016/B978-0-12-822859-3.00012-2
  52. Ahmad Mobed, Sanam Dolati, Seyed Kazem Shakouri, Bina Eftekharsadat, Behzad Izadseresht. Recent advances in biosensors for detection of osteoarthritis and rheumatoid arthritis biomarkers. Sensors and Actuators A: Physical 2021, 331 , 112975. https://doi.org/10.1016/j.sna.2021.112975
  53. Deniz Umut Yildirim, Amir Ghobadi, Ekmel Ozbay. Nanosensors Based on Localized Surface Plasmon Resonance. 2021, 23-54. https://doi.org/10.1002/9783527830343.ch2
  54. J. Rafaela L. Guerreiro, Andrey Ipatov, Joana Carvalho, Anna Toldrà, Marta Prado. Amplified plasmonic and microfluidic setup for DNA monitoring. Microchimica Acta 2021, 188 (10) https://doi.org/10.1007/s00604-021-04983-y
  55. Aref Asghari, Chao Wang, Kyoung Min Yoo, Ali Rostamian, Xiaochuan Xu, Jong-Dug Shin, Hamed Dalir, Ray T. Chen. Fast, accurate, point-of-care COVID-19 pandemic diagnosis enabled through advanced lab-on-chip optical biosensors: Opportunities and challenges. Applied Physics Reviews 2021, 8 (3) https://doi.org/10.1063/5.0022211
  56. Thakshila Liyanage, Meimei Lai, Gymama Slaughter. Label-free tapered optical fiber plasmonic biosensor. Analytica Chimica Acta 2021, 1169 , 338629. https://doi.org/10.1016/j.aca.2021.338629
  57. María A. Ortega, Júlia Rodríguez-Comas, Ozlem Yavas, Ferran Velasco-Mallorquí, Jordina Balaguer-Trias, Victor Parra, Anna Novials, Joan M. Servitja, Romain Quidant, Javier Ramón-Azcón. In Situ LSPR Sensing of Secreted Insulin in Organ-on-Chip. Biosensors 2021, 11 (5) , 138. https://doi.org/10.3390/bios11050138
  58. Xi Hu, Fan Xia, Jiyoung Lee, Fangyuan Li, Xiaoyang Lu, Xiaozhen Zhuo, Guangjun Nie, Daishun Ling. Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma. Advanced Science 2021, 8 (7) https://doi.org/10.1002/advs.202002545
  59. Fatemeh Farshchi, Arezoo Saadati, Nazanin Fathi, Mohammad Hasanzadeh, Mohammad Samiei. Flexible paper-based label-free electrochemical biosensor for the monitoring of miRNA-21 using core–shell Ag@Au/GQD nano-ink: a new platform for the accurate and rapid analysis by low cost lab-on-paper technology. Analytical Methods 2021, 13 (10) , 1286-1294. https://doi.org/10.1039/D1AY00142F
  60. B. Miranda, R. Moretta, S. De Martino, P. Dardano, I. Rea, C. Forestiere, L. De Stefano. A PEGDA hydrogel nanocomposite to improve gold nanoparticles stability for novel plasmonic sensing platforms. Journal of Applied Physics 2021, 129 (3) https://doi.org/10.1063/5.0033520
  61. Joe Otsuki, Kosuke Sugawa, Shota Jin. Plasmonic triangular nanoprism sensors. Materials Advances 2021, 2 (1) , 32-46. https://doi.org/10.1039/D0MA00644K
  62. Masoud Shabaninezhad, Asghar Kayani, Guda Ramakrishna. Theoretical investigation of optical properties of embedded plasmonic nanoparticles. Chemical Physics 2021, 541 , 111044. https://doi.org/10.1016/j.chemphys.2020.111044
  63. Yongmei Yao, Yang Liu, Fengqin Jin, Zhaohua Meng. LINC00662 Promotes Oral Squamous Cell Carcinoma Cell Growth and Metastasis through miR-144-3p/EZH2 Axis. Yonsei Medical Journal 2021, 62 (7) , 640. https://doi.org/10.3349/ymj.2021.62.7.640
  64. Amit Kumar Dubey, Prakash Kumar, Debabrata Mandal, V Ravichandiran, Shubhankar Kumar Singh. Modified Geno-Nanosensing: A Ultrasensitive Colorimetric Assay/ Nanoenzyme for mRNA Quantification (Upto Famtogram) Via Thiolated Probe-HRP-Conjugated GNP. SSRN Electronic Journal 2021, 12 https://doi.org/10.2139/ssrn.3883866
  65. Shirsendu Mitra, Mitali Basak, Dipankar Bandyopadhyay. Multifunctional gold nanoparticles for biosensing. 2021, 331-366. https://doi.org/10.1016/B978-0-12-822352-9.00012-2
  66. Neeli Chandran, Manikanta Bayal, Rajendra Pilankatta, Swapna S. Nair. Advances in Plasmonic Biosensors and Their Futuristic Applications. 2021, 67-82. https://doi.org/10.1007/978-981-16-5367-4_5
  67. Khouloud Djebbi, Mohamed Bahri, Mohamed Amin Elaguech, Rong Tian, Shi Biao, Chaker Tlili, Deqiang Wang. Recent Advances in Ultrasensitive miRNA Biomarkers Detection. 2021, 137-164. https://doi.org/10.1007/978-3-030-71225-9_9
  68. Thakshila Liyanage, Adrianna N. Masterson, Sumon Hati, Greta Ren, Nicholas E. Manicke, Daniel E. Rusyniak, Rajesh Sardar. Optimization of electromagnetic hot spots in surface-enhanced Raman scattering substrates for an ultrasensitive drug assay of emergency department patients’ plasma. The Analyst 2020, 145 (23) , 7662-7672. https://doi.org/10.1039/D0AN01372B
  69. Andrea Miti, Sophie Thamm, Philipp Müller, Andrea Csáki, Wolfgang Fritzsche, Giampaolo Zuccheri. A miRNA biosensor based on localized surface plasmon resonance enhanced by surface-bound hybridization chain reaction. Biosensors and Bioelectronics 2020, 167 , 112465. https://doi.org/10.1016/j.bios.2020.112465
  70. José Javier Imas, Carlos Ruiz Zamarreño, Pablo Zubiate, Lorena Sanchez-Martín, Javier Campión, Ignacio Raúl Matías. Optical Biosensors for the Detection of Rheumatoid Arthritis (RA) Biomarkers: A Comprehensive Review. Sensors 2020, 20 (21) , 6289. https://doi.org/10.3390/s20216289
  71. Maria Moccia, Veronica Caratelli, Stefano Cinti, Biagio Pede, Concetta Avitabile, Michele Saviano, Anna Lisa Imbriani, Danila Moscone, Fabiana Arduini. Paper-based electrochemical peptide nucleic acid (PNA) biosensor for detection of miRNA-492: a pancreatic ductal adenocarcinoma biomarker. Biosensors and Bioelectronics 2020, 165 , 112371. https://doi.org/10.1016/j.bios.2020.112371
  72. Aviru Kumar Basu, Adreeja Basu, Shantanu Bhattacharya. Micro/Nano fabricated cantilever based biosensor platform: A review and recent progress. Enzyme and Microbial Technology 2020, 139 , 109558. https://doi.org/10.1016/j.enzmictec.2020.109558
  73. Adrianna N. Masterson, Thakshila Liyanage, Claire Berman, Hristos Kaimakliotis, Merrell Johnson, Rajesh Sardar. A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses. The Analyst 2020, 145 (12) , 4173-4180. https://doi.org/10.1039/D0AN00538J
  74. Weslley Felix de Oliveira, Priscila Marcelino dos Santos Silva, Luana Cassandra Breitenbach Barroso Coelho, Maria Tereza dos Santos Correia. Biomarkers, Biosensors and Biomedicine. Current Medicinal Chemistry 2020, 27 (21) , 3519-3533. https://doi.org/10.2174/0929867326666190124103125
  75. Thanh Tran-Phu, Rahman Daiyan, Zelio Fusco, Zhipeng Ma, Lina Raihana Abd Rahim, Alexander Kiy, Patrick Kluth, Xuyun Guo, Ye Zhu, Hongjun Chen, Rose Amal, Antonio Tricoli. Multifunctional nanostructures of Au–Bi 2 O 3 fractals for CO 2 reduction and optical sensing. Journal of Materials Chemistry A 2020, 8 (22) , 11233-11245. https://doi.org/10.1039/D0TA01723J
  76. Michael López Mujica, Yuanyuan Zhang, Féthi Bédioui, Fabiana Gutiérrez, Gustavo Rivas. Label-free graphene oxide–based SPR genosensor for the quantification of microRNA21. Analytical and Bioanalytical Chemistry 2020, 412 (15) , 3539-3546. https://doi.org/10.1007/s00216-020-02593-w
  77. Fatih Inci, Yeşeren Saylan, Amideddin Mataji Kojouri, Mehmet Giray Ogut, Adil Denizli, Utkan Demirci. A disposable microfluidic-integrated hand-held plasmonic platform for protein detection. Applied Materials Today 2020, 18 , 100478. https://doi.org/10.1016/j.apmt.2019.100478
  78. Jagotamoy Das, Shana O. Kelley. High‐Performance Nucleic Acid Sensors for Liquid Biopsy Applications. Angewandte Chemie International Edition 2020, 59 (7) , 2554-2564. https://doi.org/10.1002/anie.201905005
  79. Jagotamoy Das, Shana O. Kelley. High‐Performance Nucleic Acid Sensors for Liquid Biopsy Applications. Angewandte Chemie 2020, 132 (7) , 2574-2584. https://doi.org/10.1002/ange.201905005
  80. Juanjuan Liu, Mahsa Jalali, Sara Mahshid, Sebastian Wachsmann-Hogiu. Are plasmonic optical biosensors ready for use in point-of-need applications?. The Analyst 2020, 145 (2) , 364-384. https://doi.org/10.1039/C9AN02149C
  81. Lingling Ou, Ting Sun, Minyi Liu, Ye Zhang, Zhiying Zhou, Xiaozhen Zhan, Lihong Lu, Qingtong Zhao, Renfa Lai, Longquan Shao. <p>Efficient miRNA Inhibitor Delivery with Graphene Oxide-Polyethylenimine to Inhibit Oral Squamous Cell Carcinoma</p>. International Journal of Nanomedicine 2020, Volume 15 , 1569-1583. https://doi.org/10.2147/IJN.S220057
  82. N. Scott Lynn, Tomáš Špringer, Jiří Slabý, Barbora Špačková, Michaela Gráfová, Maria Laura Ermini, Jiří Homola. Analyte transport to micro- and nano-plasmonic structures. Lab on a Chip 2019, 19 (24) , 4117-4127. https://doi.org/10.1039/C9LC00699K
  83. Lisheng Qian, Qiaobin Li, Kwaku Baryeh, Wanwei Qiu, Kun Li, Jing Zhang, Qingcai Yu, Dongqin Xu, Wenju Liu, Randall E. Brand, Xueji Zhang, Wei Chen, Guodong Liu. Biosensors for early diagnosis of pancreatic cancer: a review. Translational Research 2019, 213 , 67-89. https://doi.org/10.1016/j.trsl.2019.08.002
  84. Meimei Lai, Gymama Slaughter. Label-Free MicroRNA Optical Biosensors. Nanomaterials 2019, 9 (11) , 1573. https://doi.org/10.3390/nano9111573
  85. Noemi Bellassai, Roberta D'Agata, Vanessa Jungbluth, Giuseppe Spoto. Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis. Frontiers in Chemistry 2019, 7 https://doi.org/10.3389/fchem.2019.00570
  86. Dandan Wang, Xiaolong Xu, Ya Zhou, Haijuan Li, Guohua Qi, Ping Hu, Yongdong Jin. Short-chain oligonucleotide detection by glass nanopore using targeting-induced DNA tetrahedron deformation as signal amplifier. Analytica Chimica Acta 2019, 1063 , 57-63. https://doi.org/10.1016/j.aca.2019.02.058
  87. Masoud Shabaninezhad, Guda Ramakrishna. Theoretical investigation of size, shape, and aspect ratio effect on the LSPR sensitivity of hollow-gold nanoshells. The Journal of Chemical Physics 2019, 150 (14) https://doi.org/10.1063/1.5090885
  88. Alireza Gharatape, Ahmad Yari Khosroushahi. Optical Biomarker-based Biosensors for Cancer/Infectious Disease Medical Diagnoses. Applied Immunohistochemistry & Molecular Morphology 2019, 27 (4) , 278-286. https://doi.org/10.1097/PAI.0000000000000586
  89. Abdul Shakoor, James Grant, Marco Grande, David. R. S. Cumming. Towards Portable Nanophotonic Sensors. Sensors 2019, 19 (7) , 1715. https://doi.org/10.3390/s19071715
  90. Lenka Michálková, Štěpán Horník, Jan Sýkora, Lucie Habartová, Vladimír Setnička. Diagnosis of pancreatic cancer via 1 H NMR metabolomics of human plasma. The Analyst 2018, 143 (24) , 5974-5978. https://doi.org/10.1039/C8AN01310A
  91. Chen Zhou, Haimin Zou, Chengjun Sun, Dongxia Ren, Jing Chen, Yongxin Li. Signal amplification strategies for DNA-based surface plasmon resonance biosensors. Biosensors and Bioelectronics 2018, 117 , 678-689. https://doi.org/10.1016/j.bios.2018.06.062
  92. Fang Hu, Wancun Zhang, Jiaqi Zhang, Qi Zhang, Tao Sheng, Yueqing Gu. An electrochemical biosensor for sensitive detection of microRNAs based on target-recycled non-enzymatic amplification. Sensors and Actuators B: Chemical 2018, 271 , 15-23. https://doi.org/10.1016/j.snb.2018.05.081
  93. Li Sun, David G. Meckes. Methodological Approaches to Study Extracellular Vesicle miRNAs in Epstein–Barr Virus-Associated Cancers. International Journal of Molecular Sciences 2018, 19 (9) , 2810. https://doi.org/10.3390/ijms19092810
  94. Wancun Zhang, Jiaqi Zhang, Qi Zhang, Fang Hu, Wujuan Han, Yueqing Gu. Highly specific real-time qualification of diverse microRNAs in tissue and serum using universal molecular beacon. Sensors and Actuators B: Chemical 2018, 262 , 153-161. https://doi.org/10.1016/j.snb.2018.01.236
  95. Lucie Habartová, Bohuš Bunganič, Michal Tatarkovič, Miroslav Zavoral, Jana Vondroušová, Kamila Syslová, Vladimír Setnička. Chiroptical spectroscopy and metabolomics for blood‐based sensing of pancreatic cancer. Chirality 2018, 30 (5) , 581-591. https://doi.org/10.1002/chir.22834
  96. Andrea Csáki, Ondrej Stranik, Wolfgang Fritzsche. Localized surface plasmon resonance based biosensing. Expert Review of Molecular Diagnostics 2018, 18 (3) , 279-296. https://doi.org/10.1080/14737159.2018.1440208
  97. Wancun Zhang, Fang Hu, Qi Zhang, Jiaqi Zhang, Yibo Mao, Peng Wang, Yueqing Gu. Sensitive and specific detection of microRNAs based on two-stage amplification reaction using molecular beacons as turn-on probes. Talanta 2018, 179 , 685-692. https://doi.org/10.1016/j.talanta.2017.11.068
  98. Wancun Zhang, Jiaqi Zhang, Qi Zhang, Fang Hu, Yueqing Gu. Highly specific real-time quantification of diverse microRNAs in human samples using universal primer set frame. Analytical Biochemistry 2018, 543 , 71-78. https://doi.org/10.1016/j.ab.2017.12.004
  99. Abdul Rahim Ferhan, Joshua A. Jackman, Jae Hyeon Park, Nam-Joon Cho, Dong-Hwan Kim. Nanoplasmonic sensors for detecting circulating cancer biomarkers. Advanced Drug Delivery Reviews 2018, 125 , 48-77. https://doi.org/10.1016/j.addr.2017.12.004
  100. Xiaolei Peng, Bharath Bangalore Rajeeva, Daniel Teal, Yuebing Zheng. Plasmofluidics for Biosensing and Medical Diagnostics. 2018, 213-247. https://doi.org/10.1007/978-3-662-56333-5_5
Load all citations
Open PDF

Nano Letters

Cite this: Nano Lett. 2014, 14, 12, 6955–6963
Click to copy citationCitation copied!
https://doi.org/10.1021/nl503220s
Published November 7, 2014

Copyright © 2014 American Chemical Society. This publication is licensed under these Terms of Use.

Article Views

6036

Altmetric

-

Citations

Learn about these metrics

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

  • Abstract

    Figure 1

    Figure 1. Design of plasmonic biosensors and detecting miR-X in various physiological media. (a) Chemically synthesized and freshly prepared gold nanoprisms were covalently attached onto a 3-mercaptopropyltriethoxysilane-functionalized glass coverslip (substrate). (b) Surface of gold nanoprisms was chemically modified with a 1.0 μM 1:1 mixture of SH-C6-ssDNA-X and PEG6-SH in PBS buffer (pH 7.4) to prepare the plasmonic biosensor. (c) Incubation of sensor in miR-X solution and formation of DNA duplex. (d) Schematic of the extinction spectrum of the biosensor collected in PBS buffer after modification with a 1.0 μM 1:1 mixture of SH-C6-ssDNA-X and PEG6-SH (blue curve). The extinction spectrum was again collected after incubation in miR-X solution and careful rinsing with PBS buffer to determine the new peak position (red curve). The extent of LSPR dipole peak shift (ΔλLSPR) depends on the concentration of miR-X used during the incubation in (c), which ranged from 100 nM to 50 fM. (e) Plot of ΔλLSPR versus log of miR-X concentrations used to determine the limit of detection. The image is not to scale.

    Figure 2

    Figure 2. MicroRNA detection using label-free plasmonic biosensors. (a) Monitoring LSPR dipole peak (λLSPR) changes by UV–visible absorption spectra of gold nanoprisms during various functionalization steps: before (black, λLSPR = 800 nm) and after functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-21/PEG6-SH (red, λLSPR = 821 nm), and after incubation with 100 nM miR-21 solution in PBS buffer (blue, λLSPR = 839 nm). (b) average λLSPR peak shift (ΔλLSPR) of gold nanoprisms functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-21/PEG6-SH after incubation in different concentrations of miR-21 in PBS buffer (red triangles), 40% human plasma (black squares), and 40% bovine plasma (blue diamonds). The ΔλLSPR were calculated by taking the difference between the λLSPR peak position of the plasmonic biosensor after and before the hybridization with miR-21 in the various media. (c) Average ΔλLSPR of the plasmonic biosensor functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-10b/PEG6-SH after hybridization with different miR-10b concentrations in PBS buffer (red triangles), in 40% human plasma (black squares), and in 40% bovine plasma (blue diamonds). All extinction spectra recorded after miR-X incubation were measured in PBS buffer after rinsing with PBS buffer.

    Figure 3

    Figure 3. Determining the optimum detection condition. (a) UV–visible extinction spectra monitoring the LSPR dipole peak (λLSPR) of gold nanoprisms attached to silanized glass substrate before (black, λLSPR = 796 nm) and after (red, λLSPR = 811 nm) functionalization with 1 μM of HS-C6-ssDNA-21 without PEG6-SH spacers and after incubation in 100 nM miR-21 solution in 40% human plasma (blue, λLSPR = 822 nm). (b) Average ΔλLSPR of these HS-C6-ssDNA-21 functionalized gold nanoprisms upon hybridization with different miR-21 concentrations in 40% human plasma. The ΔλLSPR were calculated by taking the difference between the λLSPR peak position of the nanoprisms after and before the incubation with miR-21 in PBS buffer.

    Figure 4

    Figure 4. Characterization of the plasmonic biosensors regeneration ability. (a) UV–visible extinction spectra of gold nanoprisms functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-21/PEG6-SH (red, λLSPR = 818 nm) attached to silanized glass, after incubation with 100 nM of miR-21 (blue, λLSPR = 832 nm), after treatment with 15 units of RNase H for 2 h (red dotted, λLSPR = 818 nm), and after rehybridized with 100 nM of miR-21 (blue dotted, λLSPR = 832 nm). (b) Changes in LSPR dipole peak position (λLSPR) of gold nanoprisms functionalized with a 1 μM/1 μM ratio of HS-C6-ssDNA-21/PEG6-SH upon hybridization and dehybridization with miR-21 for several cycles. The λLSPR peak shifts back and forth upon sensor regeneration with RNase H by cleaving DNA/RNA duplex and rehybridization after incubation into 100 nM miR-21 in 40% human plasma. After each of the dehybridization steps, the plasmonic biosensors were thoroughly rinsed with PBS buffer to completely remove enzyme RNase H.

    Figure 5

    Figure 5. Surface characterization of the plasmonic biosensors. Atomic force microscopy images of gold nanoprisms bound to silanized glass substrate (a) after functionalization with 1:1 ratio of HS-C6-ssDNA-21/PEG6-SH (b) and after hybridization with100 nM miR-21 in 40% human plasma (c). The measurements were conducted in air. (d) Changes in the surface area of gold nanoprisms after each functionalization steps. Forty nanoprisms were selected to determine the average change in the surface area. Detailed method of surface area calculation is provided in the Supporting Information file.

    Figure 6

    Figure 6. Determination of microRNA concentration in PDAC patients and normal control subjects. (a) The average λLSPR peak shifts of gold nanoprisms functionalized with a 1:1 ratio of HS-C6-ssDNA-21/PEG6-SH upon hybridization with miR-21 from the total RNAs extracted from plasma samples of PDAC patients (blue diamonds) and normal control subjects (blue squares). The respective λLSPR peak shifts were converted to concentrations using the calibration curve established for miR-21 in PBS buffer as shown in Figure 2b [PDAC patients (red triangles), and for normal control subjects (red circles)]. (b) Comparison of miR-21 concentration for six PDAC patients determined using plasmonic biosensors (blue diamond) and qRT-PCR (red square). (c) Similar experiments were conducted to detect miR-10b where the λLSPR peak shifts and concentrations for PDAC patients are shown in blue diamonds and red triangles, respectively. The λLSPR peak shifts (blue squares) and concentrations (red circles) for normal controls are shown for comparison. (d) The average λLSPR peak shifts (blue diamonds) and concentration (red triangles) for the miR-21 in plasma samples from PDAC patients without any purification.

  • References


    This article references 60 other publications.

    1. 1
      Siegel, R.; Ma, J.; Zou, Z.; Jemal, A. Ca: Cancer J. Clin. 2014, 64, 9 29
    2. 2
      Bartel, D. P. Cell 2004, 116, 281 297
    3. 3
      Winter, J.; Jung, S.; Keller, S.; Gregory, R. I.; Diederichs, S. Nat. Cell Biol. 2009, 11, 228 234
    4. 4
      Esquela-Kerscher, A.; Slack, F. J. Nat. Rev. Cancer 2006, 6, 259 269
    5. 5
      He, L.; Thomson, J. M.; Hemann, M. T.; Hernando-Monge, E.; Mu, D.; Goodson, S.; Powers, S.; Cordon-Cardo, C.; Lowe, S. W.; Hannon, G. J.; Hammond, S. M. Nature 2005, 435, 828 833
    6. 6
      Szafranska, A. E.; Doleshal, M.; Edmunds, H. S.; Gordon, S.; Luttges, J.; Munding, J. B.; Barth, R. J.; Gutmann, E. J.; Suriawinata, A. A.; Marc Pipas, J.; Tannapfel, A.; Korc, M.; Hahn, S. A.; Labourier, E.; Tsongalis, G. J. Clin. Chem. 2008, 54, 1716 1724
    7. 7
      Setoyama, T.; Zhang, X.; Natsugoe, S.; Calin, G. A. Clin. Cancer Res. 2011, 17, 5527 5529
    8. 8
      Ouyang, H.; Gore, J.; Deitz, S.; Korc, M. Oncogene 2014, 33, 4664 4674
    9. 9
      Fang, S.; Lee, H. J.; Wark, A. W.; Corn, R. M. J. Am. Chem. Soc. 2006, 128, 14044 14046
    10. 10
      Li, J.; Yao, B.; Huang, H.; Wang, Z.; Sun, C.; Fan, Y.; Chang, Q.; Li, S.; Wang, X.; Xi, J. Anal. Chem. 2009, 81, 5446 5451
    11. 11
      Chen, C.; Ridzon, D. A.; Broomer, A. J.; Zhou, Z.; Lee, D. H.; Nguyen, J. T.; Barbisin, M.; Xu, N. L.; Mahuvakar, V. R.; Andersen, M. R.; Lao, K. Q.; Livak, K. J.; Guegler, K. J. Nucleic Acids Res. 2005, 33, e179
    12. 12
      Johnson, B. N.; Mutharasan, R. Anal. Chem. 2012, 84, 10426 10436
    13. 13
      Ramnani, P.; Gao, Y.; Ozsoz, M.; Mulchandani, A. Anal. Chem. 2013, 85, 8061 8064
    14. 14
      Cissell, K. A.; Rahimi, Y.; Shrestha, S.; Hunt, E. A.; Deo, S. K. Anal. Chem. 2008, 80, 2319 2325
    15. 15
      Qavi, A. J.; Bailey, R. C. Angew. Chem., Int. Ed. 2010, 49, 4608 4611
    16. 16
      Wang, Y.; Zheng, D.; Tan, Q.; Wang, M. X.; Gu, L.-Q. Nat. Nanotechnol. 2011, 6, 668 674
    17. 17
      Wanunu, M.; Dadosh, T.; Ray, V.; Jin, J.; McReynolds, L.; Drndic, M. Nat. Nanotechnol. 2010, 5, 807 814
    18. 18
      Lee, H.; Park, J.-E.; Nam, J.-M. Nat. Commun. 2014, 5, 1 7
    19. 19
      Jain, P. K.; Huang, X.; El-Sayed, I. H.; El-Sayed, M. A. Acc. Chem. Res. 2008, 41, 1578 1586
    20. 20
      Halas, N. J.; Lal, S.; Chang, W.-S.; Link, S.; Nordlander, P. Chem. Rev. 2011, 111, 3913 3961
    21. 21
      Mayer, K. M.; Hafner, J. H. Chem. Rev. 2011, 111, 3828 3857
    22. 22
      Jin, R.; Cao, Y.; Mirkin, C. A.; Kelly, K. L.; Schatz, G. C.; Zheng, J. G. Science 2001, 294, 1901 1903
    23. 23
      Sun, Y.; Xia, Y. Science 2002, 298, 2176 2179
    24. 24
      Anker, J. N.; Hall, W. P.; Lyandres, O.; Shah, N. C.; Zhao, J.; Van Duyne, R. P. Nat. Mater. 2008, 7, 442 453
    25. 25
      Weiss, P. S. Acc. Chem. Res. 2008, 41, 1772 1781
    26. 26
      Yan, Y.; Chen, J. I. L.; Ginger, D. S. Nano Lett. 2012, 12, 2530 2536
    27. 27
      Saha, K.; Agasti, S. S.; Kim, C.; Li, X.; Rotello, V. M. Chem. Rev. 2012, 112, 2739 2779
    28. 28
      Stewart, M. E.; Anderton, C. R.; Thompson, L. B.; Maria, J.; Gray, S. K.; Rogers, J. A.; Nuzzo, R. G. Chem. Rev. 2008, 108, 494 521
    29. 29
      Beeram, S. R.; Zamborini, F. P. J. Am. Chem. Soc. 2009, 131, 11689 11691
    30. 30
      Chen, S.; Svedendahl, M.; Duyne, R. P. V.; Käll, M. Nano Lett. 2011, 11, 1826 1830
    31. 31
      Chen, Y.; Munechika, K.; Ginger, D. S. Nano Lett. 2007, 7, 690 696
    32. 32
      Haes, A. J.; Hall, W. P.; Chang, L.; Klein, W. L.; Van Duyne, R. P. Nano Lett. 2004, 4, 1029 1034
    33. 33
      Stranahan, S. M.; Willets, K. A. Nano Lett. 2010, 10, 3777 3784
    34. 34
      Elghanian, R.; Storhoff, J. J.; Mucic, R. C.; Letsinger, R. L.; Mirkin, C. A. Science 1997, 277, 1078 1081
    35. 35
      Willets, K. A.; Van Duyne, R. P. Annu. Rev. Phys. Chem. 2007, 58, 267 297
    36. 36
      Malinsky, M. D.; Kelly, K. L.; Schatz, G. C.; Van Duyne, R. P. J. Am. Chem. Soc. 2001, 123, 1471 1482
    37. 37
      Nusz, G. J.; Curry, A. C.; Marinakos, S. M.; Wax, A.; Chilkoti, A. ACS Nano 2009, 3, 795 806
    38. 38
      Jackson, J. B.; Westcott, S. L.; Hirsch, L. R.; West, J. L.; Halas, N. J. Appl. Phys. Lett. 2003, 82, 257 259
    39. 39
      Hao, E.; Schatz, G. C. J. Chem. Phys. 2004, 120, 357 366
    40. 40
      Sherry, L. J.; Jin, R.; Mirkin, C. A.; Schatz, G. C.; Van Duyne, R. P. Nano Lett. 2006, 6, 2060 2065
    41. 41
      Chen, H.; Shao, L.; Woo, K. C.; Ming, T.; Lin, H.-Q.; Wang, J. J. Phys. Chem. C 2009, 113, 17691 17697
    42. 42
      Joshi, G. K.; McClory, P. J.; Muhoberac, B. B.; Kumbhar, A.; Smith, K. A.; Sardar, R. J. Phys. Chem. C 2012, 116, 20990 21000
    43. 43
      Joshi, G. K.; McClory, P. J.; Dolai, S.; Sardar, R. J. Mater. Chem. 2012, 22, 923 931
    44. 44
      Haes, A. J.; Zou, S.; Zhao, J.; Schatz, G. C.; Van Duyne, R. P. J. Am. Chem. Soc. 2006, 128, 10905 10914
    45. 45
      Hall, W. P.; Modica, J.; Anker, J.; Lin, Y.; Mrksich, M.; Van Duyne, R. P. Nano Lett. 2011, 11, 1098 1105
    46. 46
      McFarland, A. D.; Van Duyne, R. P. Nano Lett. 2003, 3, 1057 1062
    47. 47
      Bain, C. D.; Whitesides, G. M. J. Am. Chem. Soc. 1989, 111, 7164 7175
    48. 48
      Murphy, C. J.; Gole, A. M.; Stone, J. W.; Sisco, P. N.; Alkilany, A. M.; Goldsmith, E. C.; Baxter, S. C. Acc. Chem. Res. 2008, 41, 1721 1730
    49. 49
      Joshi, G. K.; Blodgett, K. N.; Muhoberac, B. B.; Johnson, M. A.; Smith, K. A.; Sardar, R. Nano Lett. 2014, 14, 532 540
    50. 50
      Preis, M.; Gardner, T. B.; Gordon, S. R.; Pipas, J. M.; Mackenzie, T. A.; Klein, E. E.; Longnecker, D. S.; Gutmann, E. J.; Sempere, L. F.; Korc, M. Clin. Cancer Res. 2011, 17, 5812 5821
    51. 51
      Sempere, L. F.; Preis, M.; Yezefski, T.; Ouyang, H.; Suriawinata, A. A.; Silahtaroglu, A.; Conejo-Garcia, J. R.; Kauppinen, S.; Wells, W.; Korc, M. Clin. Cancer Res. 2010, 16, 4246 4255
    52. 52
      Elhadj, S.; Singh, G.; Saraf, R. F. Langmuir 2004, 20, 5539 5543
    53. 53
      Greither, T.; Grochola, L. F.; Udelnow, A.; Lautenschläger, C.; Würl, P.; Taubert, H. Int. J. Cancer 2010, 126, 73 80
    54. 54
      Stiles, P. L.; Dieringer, J. A.; Shah, N. C.; Van Duyne, R. P. Annu. Rev. Anal. Chem. 2008, 1, 601 626
    55. 55
      Moskovits, M. J. Raman Spectrosc. 2005, 36, 485 496
    56. 56
      Singh, A. K.; Khan, S. A.; Fan, Z.; Demeritte, T.; Senapati, D.; Kanchanapally, R.; Ray, P. C. J. Am. Chem. Soc. 2012, 134, 8662 8669
    57. 57
      Jackson, J. B.; Halas, N. J. Proc. Nat. Acad. Sci. U.S.A. 2004, 101, 17930 17935
    58. 58
      Otte, M. A.; Sepulveda, B.; Ni, W.; Juste, J. P.; Liz-Marzan, L. M.; Lechuga, L. M. ACS Nano 2009, 4, 349 357
    59. 59
      Novo, C.; Funston, A. M.; Mulvaney, P. Nat. Nanotechnol. 2008, 3, 598 602
    60. 60
      Livak, K. J.; Schmittgen, T. D. Methods 2001, 25, 402 408
  • Supporting Information

    Supporting Information


    Experimental detail of nanoprisms synthesis, fabrication of plasmonic biosensors, and additional UV–visible spectra, AFM images, and histograms. This material is available free of charge via the Internet at http://pubs.acs.org.


    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.